Resistant Hypertension in Chronic Kidney Disease

(Brent) #1
167


  1. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG.  Sympathetic overactivity as a
    cause of hypertension in chronic renal failure. J Hypertens. 2002;20:3–9.

  2. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, et al. Early sympa-
    thetic activation in the initial clinical stages of chronic renal failure. Hypertension.
    2011;57:846–51. doi:10.1161/HYPERTENSIONAHA.110.164780.

  3. Salman IM, Hildreth CM, Ameer OZ, Phillips JK.  Differential contribution of afferent and
    central pathways to the development of baroreflex dysfunction in chronic kidney disease.
    Hypertension. 2014;63:804–10. doi:10.1161/HYPERTENSIONAHA.113.02110.

  4. Hoch H, Stegbauer J, Potthoff SA, Hein L, Quack I, Rump LC, et al. Regulation of renal sym-
    pathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.
    Br J Pharmacol. 2011;163:438–46. doi:10.1111/j.1476-5381.2011.01223.x.

  5. Tomiyama O, Shiigai T, Ideura T, Tomita K, Mito Y, Shinohara S, et al. Baroreflex sensitivity
    in renal failure. Clin Sci. 1980;58:21–7.

  6. Wallbach M, Lehnig LY, Schroer C, Hasenfuss G, Müller GA, Wachter R, et  al. Impact of
    baroreflex activation therapy on renal function—a pilot study. Am J Nephrol. 2014;40:371–80.
    doi:10.1159/000368723.

  7. Beige J, Koziolek MJ, Hennig G, Hamza A, Wendt R, Müller GA, et al. Baroreflex activation
    therapy in patients with end-stage renal failure: proof of concept. J Hypertens. 2015;33:2344–
    9. doi:10.1097/HJH.0000000000000697.

  8. Ameer OZ, Hildreth CM, Phillips JK.  Sympathetic overactivity prevails over the vascular
    amplifier phenomena in a chronic kidney disease rat model of hypertension. Physiol Rep.
    2014;2 doi:10.14814/phy2.12205.

  9. Salman IM, Sarma Kandukuri D, Harrison JL, Hildreth CM, Phillips JK.  Direct conscious
    telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with
    chronic kidney disease. Front Physiol. 2015;6:218. doi:10.3389/fphys.2015.00218.

  10. Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, et al. Renal denervation pre-
    serves renal function in patients with chronic kidney disease and resistant hypertension.
    J Hypertens. 2015;33:1261–6. doi:10.1097/HJH.0000000000000556.

  11. Kiuchi MG, Graciano ML, Carreira MA, Kiuchi T, Chen S, Lugon JR. Long-term effects of
    renal sympathetic denervation on hypertensive patients with mild to moderate chronic kidney
    disease. J Clin Hypertens (Greenwich). 2016;18:190–6. doi:10.1111/jch.12724.

  12. Schmieder RE, Ott C, Schmid A, Friedrich S, Kistner I, Ditting T, et al. Adherence to antihy-
    pertensive medication in treatment-resistant hypertension undergoing renal denervation. J Am
    Heart Assoc. 2016;5 doi:10.1161/JAHA.115.002343.

  13. Zuern CS, Eick C, Rizas KD, Bauer S, Langer H, Gawaz M, et al. Impaired cardiac baroreflex
    sensitivity predicts response to renal sympathetic denervation in patients with resistant hyper-
    tension. J Am Coll Cardiol. 2013;62:2124–30. doi:10.1016/j.jacc.2013.07.046.

  14. Gmitrov J. Baroreceptor stimulation enhanced nitric oxide vasodilator responsiveness, a new
    aspect of baroreflex physiology. Microvasc Res. 2015;98:139–44. doi:10.1016/j.
    mvr.2014.11.004.

  15. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes athero-
    sclerosis in rats. Atherosclerosis. 2005;183:41–7. doi:10.1016/j.atherosclerosis.2005.03.037.

  16. Tomiyama H, Matsumoto C, Kimura K, Odaira M, Shiina K, Yamashina A. Pathophysiological
    contribution of vascular function to baroreflex regulation in hypertension. Circ J.  2014;
    78:1414–9.

  17. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity
    is associated with increased vascular calcification and arterial stiffness. Nephrol Dial
    Transplant. 2005;20:1140–7. doi:10.1093/ndt/gfh808.

  18. Hogas S, Ardeleanu S, Segall L, Serban DN, Serban IL, Hogas M, et al. Changes in arterial
    stiffness following dialysis in relation to overhydration and to endothelial function. Int Urol
    Nephrol. 2012;44:897–905. doi:10.1007/s11255-011-9933-x.

  19. Pettersen KH, Bugenhagen SM, Nauman J, Beard DA, Omholt SW.  Arterial stiffening pro-
    vides sufficient explanation for primary hypertension. PLoS Comput Biol. 2014;10:e1003634.
    doi:10.1371/journal.pcbi.1003634.


10 Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Autonomic...

Free download pdf